Goldman Sachs Group Inc Standard Biotools Inc. Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Standard Biotools Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 918,542 shares of LAB stock, worth $1.84 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
918,542
Previous 640,983
43.3%
Holding current value
$1.84 Million
Previous $1.13 Million
56.26%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding LAB
# of Institutions
142Shares Held
279MCall Options Held
27.2KPut Options Held
34.1K-
Casdin Capital, LLC New York, NY71.3MShares$143 Million10.68% of portfolio
-
Viking Global Investors LP58.7MShares$117 Million0.44% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$43.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$34.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY15.2MShares$30.5 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $157M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...